This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Vacca, G. Articles by Gillissen, A. Search for Related Content PubMed PubMed Citation Articles by Vacca, G. Articles by Gillissen, A. Social Bookmarking                         What's this?

Polymorphisms of the ß2 adrenoreceptor gene in chronic obstructive pulmonary disease

St. Georg Medical Center, Robert-Koch-Hospital, Leipzig, Germany

Kerstin Schwabe

St. Georg Medical Center, Robert-Koch-Hospital, Leipzig, Germany

Ramona Dück

St. Georg Medical Center, Robert-Koch-Hospital, Leipzig, Germany

Hans-Peter Hlawa

Schmölln, Germany

Arite Westphal

Schmölln, Germany

Stefan Pabst

University of Bonn, Medical Clinic , Department of Pneumology, Germany

Christian Grohé

Protestant Hospital, Dept. of Pulmonary Medicine, Berlin, Germany

Adrian Gillissen

St. Georg Medical Center, Robert-Koch-Hospital, Leipzig, Germany, adrian.gillissen@ sanktgeorg.de

Background: The ß2-adrenergic receptors are cell surface receptors playing a central role in the pharmacological targeting asthma and chronic obstructive pulmonary disease (COPD). Recent studies suggest that patients who are homozygous for one of the two important polymorphisms of the ß2-adrenergic receptor (ADRB2) gene at codon 16 (arginine to glycine) and 27 (glutamine to glutamate) may have a reduced response to ß2-agonists. Since smoking patients who are Gly16 homozygotes have an increased risk of airway obstruction we hypothesized that ß2-adrenoreceptor gene polymorphisms may be also a cofounder for COPD development and disease severity.

Methods: We investigated 190 COPD patients and 172 healthy volunteers in a case-control study. DNA was isolated from whole blood and ß2-AR gene polymorphisms Arg/Gly16 and Gln/Glu27 were determined using allele-specific polymerase chain reaction (PCR).

Results: In COPD patients with Gly/Gly16 was found more frequently than in healthy smokers (29.47% COPD versus 18.18% controls, p = 0.026). All other gene polymorphisms of the ADRB2 gene at codon 16 were equally distributed between groups. ß2-adrenoreceptor gene polymorphisms were neither a cofounder for COPD exacerbations ( 3 hospitalizations within the last 3 years) nor for disease severity (FEV1 30% predicted).

Conclusion: Our study suggests that the Gly16 allele of the ß2-AR gene predisposes to COPD development but not for exacerbation rates and disease severity. In contrast, Gln/Glu27 polymorphism was irrelevant in our COPD cohort.

Key Words: polymorphism • beta 2 receptor gene • COPD

Therapeutic Advances in Respiratory Disease, Vol. 3, No. 1, 3-10 (2009)
DOI: 10.1177/1753465809102553


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?